Literature DB >> 12164325

Genotype frequencies of 50 polymorphisms for 241 Japanese non-cancer patients.

Nobuyuki Hamajima1, Toshiko Saito, Keitaro Matsuo, Takashi Suzuki, Tsuneya Nakamura, Akio Matsuura, Katashi Okuma, Kazuo Tajima.   

Abstract

This paper lists the genotype frequencies of 50 polymorphisms of 37 genes (ALDH2, ADRB2, ADRB3, COMT, CD36, CXCR2, CCND1, COX2, CYP2A6, CYP17, CYP19, IGF1, IL-1A, IL-1B, IL-1RN, IL-1R1, IL-6, IL-8, IL-10, LEP, Le, L-myc, MPO, MTR, MTHFR, MAO-A, NQO1, OGG1, p53, p73, Se, SRD5A2, TGF-B, TNF-A, TNF-B, XPD, and XRCC1) and 6 sets of combined genotype frequencies for 241 non-cancer Japanese outpatients. Though the genotype frequencies of 25 polymorphisms have already been reported in our previous papers, 15 polymorphisms (CD36 A52C, CXCR2 C785T, CCND1 G870A, IGF1 C/T at intron 2 and G2502T, IL-1A 46-bp VNTR, IL-1R1 C-116T, IL-6 Ins/Del 17C, IL-8 A-278T and C74T, IL- 10 T-819C, LEP A-2548G, SRD5A2 2-bp VNTR, XPD Lys751Gln, and XRCC1 Arg399Gln) and six sets of combined genotype frequencies (IL-1B C-31T and IL-1A C-889T, IL-1B C-31T and IL-1RN 86-bp VNTR, IL-1B C-31T and IL-1R1 C-116T, TNF-A G-308A and TNF-B A252G, SRD5A2 Val89Leu and 2-bp VNTR, and XRCC1 Arg399Gln and XPD Lys751Gln) were reported in this paper for the first time for Japanese. Although microarray technology will produce this kind of information in near future, this is the first document that reports the genotype/allele frequencies among Japanese for an archival purpose.

Entities:  

Mesh:

Year:  2002        PMID: 12164325     DOI: 10.2188/jea.12.229

Source DB:  PubMed          Journal:  J Epidemiol        ISSN: 0917-5040            Impact factor:   3.211


  8 in total

1.  The role of XPD in cell apoptosis and viability and its relationship with p53 and cdk2 in hepatoma cells.

Authors:  Hong-yun Wang; Gao-fei Xiong; Ji-xiang Zhang; Hong Xu; Wu-hua Guo; Jiang-jing Xu; Xiang-yang Xiong
Journal:  Med Oncol       Date:  2011-01-25       Impact factor: 3.064

2.  Use of duplex PCR-CTPP methods for CYP2E1RsaI/IL-2 T-330G and IL-1B C-31T/TNF-A T-1031C polymorphisms.

Authors:  Yoshiko Atsuta; Haruya Kawase; Nobuyuki Hamajima; Kazuko Nishio; Yoshimitsu Niwa; Daisuke Tanaka; Kazuhito Yamamoto; Akiko Tamakoshi
Journal:  Mol Diagn       Date:  2005

3.  A new PCR method: one primer amplification of PCR-CTPP products.

Authors:  Guang Yin; Yoko Mitsuda; Takayuki Ezaki; Nobuyuki Hamajima
Journal:  Mol Biotechnol       Date:  2012-10       Impact factor: 2.695

4.  Association of leptin genetic polymorphism -2548 G/A with gestational diabetes mellitus.

Authors:  Julie Anna Bienertová Vaskú; Anna Vaskú; Zuzana Dostálová; Petr Bienert
Journal:  Genes Nutr       Date:  2006-06       Impact factor: 5.523

5.  XPD Polymorphisms and Risk of Squamous Cell Carcinoma of the Head and Neck in a Korean Sample.

Authors:  Yong Bae Ji; Kyung Tae; Yoon Seo Lee; Seung Hwan Lee; Kyung Rae Kim; Chul Won Park; Byung Lae Park; Hyoung Doo Shin
Journal:  Clin Exp Otorhinolaryngol       Date:  2010-03-30       Impact factor: 3.372

6.  Allele frequencies of single nucleotide polymorphisms (SNPs) in 40 candidate genes for gene-environment studies on cancer: data from population-based Japanese random samples.

Authors:  Kimio Yoshimura; Tomoyuki Hanaoka; Shumpei Ohnami; Sumiko Ohnami; Takashi Kohno; Ying Liu; Teruhiko Yoshida; Hiromi Sakamoto; Shoichiro Tsugane
Journal:  J Hum Genet       Date:  2003-11-21       Impact factor: 3.172

7.  Implications of XRCC1, XPD and APE1 gene polymorphism in North Indian population: a comparative approach in different ethnic groups worldwide.

Authors:  Ruchika Gangwar; Parmeet Kaur Manchanda; Rama Devi Mittal
Journal:  Genetica       Date:  2008-10-23       Impact factor: 1.082

8.  Serum folate and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism adjusted for folate intake.

Authors:  Kazuko Nishio; Yasuyuki Goto; Takaaki Kondo; Shimon Ito; Yoshiko Ishida; Sayo Kawai; Mariko Naito; Kenji Wakai; Nobuyuki Hamajima
Journal:  J Epidemiol       Date:  2008-05-14       Impact factor: 3.211

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.